Multi-Site Trial of Tirzepatide for Smoking Cessation
Public ClinicalTrials.gov record NCT07602699. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Site Trial of Tirzepatide for Smoking Cessation
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This multi-site clinical trial will generate data on the efficacy of tirzepatide for smoking cessation and associated outcomes (e.g., post-cessation weight gain) in treatment-seeking people who smoke (PWS) with overweight or obesity. A sample of 300 treatment-seeking people who smoke with body mass index of 25 kg/m2 or greater will be recruited from four geographic sites (University of Southern California, Yale University, University of Chicago, and University of Colorado Anschutz Medical Campus) to participate in a parallel-arm, dose-escalating, placebo-controlled trial. Participants will attend weekly clinic visits to receive subcutaneous tirzepatide or placebo over 16 weeks (Visit Weeks 1-16), followed by follow-up visits at Week 17 and Week 27. Medication will be prescribed according to the standard dose titration schedule for the first 16 weeks of treatment (initial dose: 2.5mg/week; final dose: 10mg/week). All participants will also receive nicotine patches.
Study identification
- NCT ID
- NCT07602699
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 4, 2026
- Primary completion
- Feb 29, 2028
- Completion
- Aug 31, 2028
- Last update posted
- Jul 16, 2026
2026 – 2028
United States locations
- U.S. sites
- 4
- U.S. states
- 4
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Keck School of Medicine, University of Southern California | Los Angeles | California | 90033 | Recruiting |
| University of Colorado Anschutz Medical Campus | Aurora | Colorado | 80045 | Recruiting |
| Yale University School of Medicine | New Haven | Connecticut | 06510 | Recruiting |
| University of Chicago Pritzker School of Medicine | Chicago | Illinois | 60637 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Smoking Behaviors trials
Other public records listing Smoking Behaviors. Sorted by last update posted; newest first. Not a recommendation.
- NCT06373679: Switch or Quit R01 Recruiting
- NCT07102082: Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product Demand Recruiting
- NCT07459621: Evaluation of a Novel mHealth Intervention for People Who Are Ambivalent About Quitting Smoking Recruiting
- NCT05000632: Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families Recruiting
- NCT06077240: Effects of E-cigs vs Pouches on Cigarette Smoking and Addiction Recruiting
- NCT07476144: Nordic Spirit Pouch Nicotine Pharmacokinetics Abuse Liability Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07602699, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 16, 2026 · Synced Aug 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07602699 live on ClinicalTrials.gov.